- Home
- ATOS vs RSSS Comparison
ATOS vs RSSS Comparison
Compare ATOS & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- RSSS
- Stock Information
- Founded
- ATOS 2009
- RSSS 2006
- Country
- ATOS United States
- RSSS United States
- Employees
- ATOS N/A
- RSSS N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- RSSS Business Services
- Sector
- ATOS Health Care
- RSSS Consumer Discretionary
- Exchange
- ATOS Nasdaq
- RSSS Nasdaq
- Market Cap
- ATOS 96.8M
- RSSS 80.0M
- IPO Year
- ATOS 2012
- RSSS N/A
- Fundamental
- Price
- ATOS $0.74
- RSSS $2.62
- Analyst Decision
- ATOS Strong Buy
- RSSS Strong Buy
- Analyst Count
- ATOS 3
- RSSS 1
- Target Price
- ATOS $7.13
- RSSS $6.00
- AVG Volume (30 Days)
- ATOS 714.9K
- RSSS 80.3K
- Earning Date
- ATOS 05-12-2025
- RSSS 05-08-2025
- Dividend Yield
- ATOS N/A
- RSSS N/A
- EPS Growth
- ATOS N/A
- RSSS N/A
- EPS
- ATOS N/A
- RSSS N/A
- Revenue
- ATOS N/A
- RSSS $48,207,887.00
- Revenue This Year
- ATOS N/A
- RSSS $13.88
- Revenue Next Year
- ATOS N/A
- RSSS $7.30
- P/E Ratio
- ATOS N/A
- RSSS N/A
- Revenue Growth
- ATOS N/A
- RSSS 18.51
- 52 Week Low
- ATOS $0.55
- RSSS $2.32
- 52 Week High
- ATOS $1.81
- RSSS $4.24
- Technical
- Relative Strength Index (RSI)
- ATOS 58.85
- RSSS 48.40
- Support Level
- ATOS $0.59
- RSSS $2.35
- Resistance Level
- ATOS $0.67
- RSSS $2.87
- Average True Range (ATR)
- ATOS 0.06
- RSSS 0.16
- MACD
- ATOS 0.01
- RSSS 0.05
- Stochastic Oscillator
- ATOS 88.47
- RSSS 54.55
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.